December 29, 2022
Read in 2 minutes
Over the past year, the United States Preventive Services Task Force has released recommendations for screening and preventive treatment for a variety of medical conditions.
One of Healio’s most popular USPSTF stories for 2022 concerns guidance on the use of hormone therapy for primary prevention of chronic disease in postmenopausal women. Recommendations are against the use of menopausal hormone therapy (MHT) with estrogen and progestin in postmenopausal people and against the use of estrogen-only MHT in postmenopausal people who have had a hysterectomy. I advocate.
Other popular stories include final recommendations to initiate aspirin for primary CVD prevention in older adults and the lack of evidence regarding the risks and benefits of sleep apnea screening in asymptomatic adults. .
Catch up on Healio’s coverage of the USPSTF’s recommendations below:
USPSTF recommends against hormone therapy to prevent postmenopausal chronic disease
The USPSTF has issued two final recommendations regarding the use of hormone therapy for the primary prevention of postmenopausal chronic disease. read more.
USPSTF Finalizes Recommendations for Starting Aspirin for Primary CVD Prevention
The USPSTF has issued final recommendations, grade D recommendations against initiation of low-dose aspirin for primary CVD prevention in adults 60 years and older. read more.
USPSTF: Insufficient Evidence on Risks, Benefits of Sleep Apnea Screening
According to the USPSTF statement, there is not yet sufficient evidence to recommend or discourage obstructive sleep apnea screening in asymptomatic adults. read more.
USPSTF Releases Draft Recommendations for Screening for Skin Cancer in Adults and Adolescents
The USPSTF has released draft recommendations stating that there is insufficient evidence to support or oppose screening of asymptomatic adults and adolescents for skin cancer. read more.
USPSTF: Beta Carotene, Vitamin E, Multivitamins in CVD, No Cancer Prevention Benefits
The USPSTF has issued a statement of recommendation against using beta-carotene or vitamin E supplements for CVD or cancer prevention. read more.
The USPSTF lacks evidence to recommend screening for atrial fibrillation.
The USPSTF states that there is insufficient evidence to recommend screening for atrial fibrillation in adults over the age of 50 who have no diagnosis, symptoms, and no history of transient ischemic attack or stroke. increase. read more.
USPSTF Finalizes Recommendations for Anxiety, Depression and Suicide Risk Screening in Youth
The USPSTF has released a final advisory statement on screening for anxiety, depression, and suicide risk in children and adolescents. read more.
USPSTF Reaffirms Syphilis Screening Recommendations
Citing the increasing incidence of syphilis infection over the past two decades, the USPSTF has reaffirmed its recommendation to screen people at high risk for infection.
USPSTF: Screening All Adults Under 65 for Anxiety
The USPSTF has released a draft historic Recommendation Statement advocating screening for anxiety disorders in adults under the age of 65. read more.
USPSTF Finalizes Recommendations for Type 2 Diabetes Screening in Prediabetes, Youth
USPSTF final recommendation jamThey state that there is insufficient evidence to assess the benefits and harms of screening for prediabetes and type 2 diabetes in asymptomatic children and adolescents. read more.